PUMA BIOTECHNOLOGY director Cesano Alessandra exercised Options for 50,000 shares at $2.93 per share on Sep 14, 2026, while also selling 62,150 shares at $9.12. Investors receive reported post-transaction holdings of 118,850 shares, 56,700 shares and 50,000 derivative securities across the listed transactions.

Key Highlights

  • Cesano Alessandra sold 62,150 PUMA BIOTECHNOLOGY shares at $9.12 per share on September 14, 2026.
  • The option exercise was followed by reported ownership of 118,850 shares, representing about 42.1% of the resulting share holding.
  • The director owned 50,000 derivative securities after an exercise representing about 50.0% of the prior derivative securities holding.

PUMA BIOTECHNOLOGY, INC. (NASDAQ: PBYI) director Cesano Alessandra exercised options for 50,000 shares at $2.93 per share on September 14, 2026. The transaction gives investors a specific view of the director’s reported share and derivative-security positions.

Option Exercise and Share Sale Details

A separate transaction on the same date involved the sale of 62,150 shares at $9.12 per share. The sale carried transaction code S, which identifies an open-market sale. The option exercise used transaction code M, the classification for an option exercise. The record also lists an exercise involving 50,000 derivative securities.

Reported Holdings After the Transactions

Following the option exercise, Cesano Alessandra held 118,850 shares, and that transaction represented about 42.1% of the resulting share holding. After the sale, the director held 56,700 shares, with the sale representing about 52.3% of the prior share holding. The derivative-security exercise represented about 50.0% of the prior derivative securities holding, leaving 50,000 derivative securities owned.